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Mixed neuroendocrine and non-neuroendocrine type of tumor in renal pelvis is rare and presents a
high-grade malignancy. We present a case report that a 57-year-old man had no history of small cell
cancer but presented a high-grade neuroendocrine carcinoma with focal squamous metaplasia and
multiple stones simultaneously in the right renal pelvis. The patient underwent nephroureter-
ocystectomy 9 months before this presentation, with evidence of multiple metastatic tumors in various
parts of the body. The case of mixed neuroendocrine tumor with stones in the renal pelvis carries a poor
prognosis and poses a therapeutic challenge to urologists.
 2014 The Authors. Published by Elsevier Inc. All rights reserved.Introduction
High-grade neuroendocrine carcinomas, which are also known
as poorly differentiated neuroendocrine carcinomas, arise more
frequently in the lung, and approximately 2.5% occur in extrap-
ulmonary sites, including the genitourinary tract.1 Neuroendocrine
tumors of the urogenital system accounts only for a small propor-
tion, and urinary bladder and prostate are the common occurrence
sites. Renal neuroendocrine tumor is a very rare and poorly differ-
entiated cancer and comprised a group of highly malignant tumor
cell types associated with poor outcome and short survival.
Compared with parenchyma-arising neuroendocrine tumors, the
pelvis-arising neuroendocrine tumors aremore rare andmore likely
to presentmixed neuroendocrine andnon-neuroendocrine type.2 In
this study,wereport a caseof high-gradeneuroendocrine carcinoma
with focal squamousmetaplasia of renal pelvis associatedwith renal
calculus, which is extremely rare. Only 2 cases of renal pelvis carci-
nomas reported in the previous English-language literature were
consistent with such histopathologic features.3,4BY-NC-SA license (http://
: þ86-21-63111100.
Published by Elsevier Inc. All righCase presentation
A 57-year-old man presented with right ﬂank pain and micro-
scopic hematuria for 15 days. Ultrasonography revealed multiple
stones in the right pelviureteral site, accompanied hydro-
ureteronephrosis and a space-occupying mass. Intravenous pyelo-
gram showed right pelviureteral nonvisualization. Computed
tomography revealed stones along with upper-ureteric thickening
and dilating and a 28  27 mm uneven enhancing mass in ureter-
opelvic junction. No enlarged mesenteric lymph nodes and retro-
peritoneal lymph nodes were observed, and no thrombus in the
renal vein and inferior vena cava (Fig. 1). Percutaneous neph-
rolithotripsy was performed to remove the stones and establish
diagnosis. Initial impression of biopsy specimens reviewed by the
pathologist was that of urothelial carcinoma with necrosis. In view
of the malignancy, the patient underwent radical nephroureter-
ocystectomy, and a nodular and sessile tumor measuring 3.0 
2.5  1.7 cm with gray-whitish cut surface was found in the
dilated pelvis of the resected specimen (Fig. 2). A ﬁnal diagnosis of
high-grade neuroendocrine carcinoma with focal squamous meta-
plasia was rendered (Fig. 3). Preoperative and postoperative sys-
temic examinations detected no tumors in other sites.
The patient did not receive chemotherapy after surgery. Six
months later, postoperative review showed some enlargedts reserved.
Figure 1. Computed tomographic plain scan shows multiple stones within the right renal pelvis and calyceal, an irregular soft tissue mass in the ureteropelvic junction (A). Uneven
enhancing visualization appears in the mass along with an upper-ureteric thickening in the enhancement scanning (B). Right hydronephrosis reconstructionwas obtained in images
(C, D).
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other anatomic sites using the computed tomography detection,
and the patient had no subjective symptoms except discomfort of
the operative site. However, 9 months after the surgery, multiple
metastatic tumors were found in the lung and liver, and the patient
presented cachexia.
Discussion
The histogenesis of high-grade neuroendocrine carcinomas,
independently of the site of origin, remains controversial and needs
further studies. Some people consider they originate from urothe-
lial cells with the neuroendocrine differentiation or neuroendo-
crine cells presenting in renal pelvis, some authors hold that these
tumors originate from the entrapped neural crest in the kidney
during embryogenesis.5 A more persuasive view based on the
theory of clinic-pathologic similarities among tumors originating inFigure 2. Macroscopically, the tumor predominantly located in the dilated renal pelvis, w
hemorrhage presents on cut sections (B).different sites is that these tumors arise from undifferentiated stem
cells with multipotential differentiation toward a neuroendocrine
and sometimes an exocrine differentiation such as squamous,
glandular, or urothelial cell lineage when these incentive factors
are present, and they tend to be of high grade.1,6 The view of stem
cells of origin can explain why the neuroendocrine and non-
neuroendocrine components can be simultaneously observed in
neuroendocrine carcinomas. For example, the neuroendocrine
component of lung and gastrointestinal tract commonly appear in
combinationwith squamous cell carcinoma or adenocarcinoma, the
neuroendocrine component of renal pelvis is frequently accompa-
nied with transitional cell carcinoma (TCC). However, the present
case we reported showed squamous metaplasia component, which
is extremely rare. Generally, TCC is the most common type in renal
pelvis neoplasmas, whereas the type of squamous cell carcinoma or
TCC with squamous metaplasia in renal pelvis is often accompanied
with incentive factors such as pyelonephritis, kidney stones, andell-circumscribed, solid and nodular (A). White-gray appearance with necrosis and
Figure 3. Microscopic ﬁndings: the tumor cells present ribbon-like, trabecular, and nest arrangement (A) (HE 100), small to intermediate in size nucleoli, scanty cytoplasm, and
poorly deﬁned cytoplasmic borders (D) (HE 400). Focal squamous metaplasia appears in pathologic sections (B) (HE 40); (C) (HE 100). Immunohistochemistry: tumor cells
present strongly positive for CD56 (E), partly positive for synaptophysin (F), neuron-speciﬁc enolase (G), and focally positive for P63 (H) and CK (I).
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stones induce the squamous metaplasia component located within
the tumor.
Although neuroendocrine carcinoma has typical morphologic
features including highly cellular atypia, high mitotic/proliferative
indices, and extensive necrosis, sometimes it is difﬁcult to make a
rapid and deﬁnite diagnosis by conventional histologic prepara-
tions. The differential diagnoses include malignant lymphoma,
lymphoepithelioma such as carcinoma, plasmacytoid carcinoma,
poorly differentiated urothelial carcinoma, and primitive neuro-
ectodermal tumor. For this case, the primary diagnosis of neph-
roscopy biopsy was urothelial carcinoma with necrosis. However,
the resected tumor was conﬁrmed to be a high-grade neuroen-
docrine carcinoma with focal squamous metaplasia by immuno-
histochemical markers, including synaptophysin, neuron-speciﬁc
enolase, CD56, and P63 (Fig. 3). As neuroendocrine carcinoma
frequently occurs in lung and gastrointestinal and rarely arises
from urogenital system, the conﬁrmation of the primary site is
important. However, no neuroendocrine carcinomas were found
in other anatomic sites before surgery, indicating this rare
neuroendocrine carcinoma might originate from urothelial
epithelium of the renal pelvis.
Hematuria and ﬂank discomfort or pain were the most frequent
clinical symptoms in the cases of renal pelvis high-gradeneuroendocrine carcinomas. Surprisingly, no endocrine syndromes
were described in these cases. This type of tumor is characterized
by an aggressive clinical course with early metastasis, and the usual
sites of metastasis are lymph nodes and bone. It has been reported
that patients with urologic poorly differentiated neuroendocrine
carcinomas treated with chemotherapy independently showed a
better survival than patients treated with surgery or combination
therapy of surgery and chemotherapy.7 However, the overall sur-
vival rate for patients with small cell carcinoma of the bladder with
local disease has been reported as low as 8%,8 and many patients
diagnosed renal high-grade neuroendocrine carcinomas died after
a few months regardless of the chosen therapeutic regimen. The
patient in our report appeared multiple metastatic tumors in the
lung and liver and progress of cachexia after radical nephrour-
eterectomy for 9 months, indicating the poor prognosis of this type
of tumor.
Conclusion
We report such a particular case: a patient with a tumor and
multiple stones simultaneously in the renal pelvis. Histologic and
immunohistochemical analyses showed that the tumor presented a
feature of high-grade neuroendocrine carcinoma with focal squa-
mous metaplasia probably induced by stones in the pelvis. Further
Y.-P. Huang et al. / Urology Case Reports 2 (2014) 93e9696studies should be required to elucidate the pathogenesis and
improve the therapy.
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